(2023) The prognostic and therapeutic potential of HO-1 in leukemia and MDS. Cell communication and signaling : CCS. p. 57. ISSN 1478-811X (Electronic) 1478-811X (Linking)

(2020) How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency. International journal of hematology-oncology and stem cell research. pp. 265-273. ISSN 2008-3009 (Print) 2008-2207 (Linking)

(UNSPECIFIED) The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies. Expert Opinion on Therapeutic Targets. p. 15. ISSN 1472-8222